Ecological Security Assessment Based on Ecological Footprint Approach in Hulunbeir Grassland, China

by Guo, Shanshan, Wang, Yinghong
Published in Int J Environ Res Public Health (2019)

Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab

by Zhang, Hao Chi, Luo, Wenyi, Wang, Yinghong
Published in J Immunother Cancer (2019)

Beneficial Metabolic Effects of 2′,3′,5′-tri-acetyl-N(6)- (3-Hydroxylaniline) Adenosine in the Liver and Plasma of Hyperlipidemic Hamsters

by Sun, Yang, Lian, Zeqin, Jiang, Chunying, Wang, Yinghong, Zhu, Haibo
Published 2012

Decoupling and Decomposition Analysis of Land Natural Capital Utilization and Economic Growth: A Case Study in Ningxia Hui Autonomous Region, China

by Guo, Shanshan, Wang, Yinghong, Huang, Jiu, Dong, Jihong, Zhang, Jian
Published in Int J Environ Res Public Health (2021)

Crystal structure of 2-aminophenylammonium— 6-oxo-1,6-dihydropyridazine- 3-carboxylate (1:1), C11H12N4O3

by Tian Chong, Nie Wanli, Wang Yinghong, Xiong Jun Ru, Borzov Maxim V.
Published 2015-06-01

Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis

by Abu-Sbeih, Hamzah, Ali, Faisal S., Luo, Wenyi, Qiao, Wei, Raju, Gottumukkala S., Wang, Yinghong
Published in J Immunother Cancer (2018)

HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma

by Ruan, Wenjing, Wang, Yinghong, Ma, Yu, Xing, Xiaoming, Lin, Jie, Cui, Jing, Lai, Maode
Published 2010

The application of HPLC and microprobe NMR spectroscopy in the identification of metabolites in complex biological matrices

by Miao, Zhaoxia, Jin, Mengxia, Liu, Xia, Guo, Wei, Jin, Xiangju, Liu, Hongyue, Wang, Yinghong
Published in Anal Bioanal Chem (2015)

The Application of Quantitative (1)H-NMR for the Determination of Orlistat in Tablets

by Sun, Shanshan, Jin, Mengxia, Zhou, Xia, Ni, Jinghua, Jin, Xiangju, Liu, Hongyue, Wang, Yinghong
Published in Molecules (2017)

Calibrations of Low-Cost Air Pollution Monitoring Sensors for CO, NO(2), O(3), and SO(2)

by Han, Pengfei, Mei, Han, Liu, Di, Zeng, Ning, Tang, Xiao, Wang, Yinghong, Pan, Yuepeng
Published in Sensors (Basel) (2021)

Management of Immune-Related Colitis During the COVID-19 Pandemic

by Amin, Rajan, Thomas, Anusha S, Khurana, Shruti, Panneerselvam, Kavea, Zou, Fangwen, Ma, Weijie, Chari, Suresh T, Wang, Yinghong
Published in Inflamm Bowel Dis (2020)

Assessment of Landscape Ecological Health: A Case Study of a Mining City in a Semi-Arid Steppe

by Wu, Zhenhua, Lei, Shaogang, He, Bao-Jie, Bian, Zhengfu, Wang, Yinghong, Lu, Qingqing, Peng, Shangui, Duo, Linghua
Published in Int J Environ Res Public Health (2019)

Dab2 gene variant is associated with increased coronary artery disease risk in Chinese Han population

by Wang, Yinghong, Wang, Yongtao, Adi, Dilare, He, XiaoDong, Liu, Fen, Abudesimu, Asiya, Fu, Zhenyan, Ma, Yitong
Published in Medicine (Baltimore) (2020)

Structure Elucidation of the Metabolites of 2', 3', 5'-Tri-O-Acetyl-N (6)-(3-Hydroxyphenyl) Adenosine in Rat Urine by HPLC-DAD, ESI-MS and Off-Line Microprobe NMR

by Guo, Wei, Jin, Mengxia, Miao, Zhaoxia, Qu, Kai, Liu, Xia, Zhang, Peicheng, Qin, Hailin, Zhu, Haibo, Wang, Yinghong
Published in PLoS One (2015)

Quantitative (1)H-NMR Method for the Determination of Tadalafil in Bulk Drugs and its Tablets

by Yang, Qingyun, Qiu, Hui, Guo, Wei, Wang, Dongmei, Zhou, Xingning, Xue, Dan, Zhang, Jinlan, Wu, Song, Wang, Yinghong
Published in Molecules (2015)

Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment

by Abu-Sbeih, Hamzah, Tran, Cynthia Nguyen, Ge, Phillip S., Bhutani, Manoop S., Alasadi, Mazen, Naing, Aung, Jazaeri, Amir A., Wang, Yinghong
Published in J Immunother Cancer (2019)

A Systematic, Integrated Study on the Neuroprotective Effects of Hydroxysafflor Yellow A Revealed by (1)H NMR-Based Metabonomics and the NF-κB Pathway

by Liu, Yuanyan, Lian, Zeqin, Zhu, Haibo, Wang, Yinghong, Yu, Shishan, Chen, Tingting, Qu, Jing, Li, Jianbei, Ma, Shuanggang, Chen, Xianhong
Published 2013

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

by Abu-Sbeih, Hamzah, Ali, Faisal S., Alsaadi, Dana, Jennings, Joseph, Luo, Wenyi, Gong, Zimu, Richards, David M., Charabaty, Aline, Wang, Yinghong
Published in J Immunother Cancer (2018)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

by Abu-Sbeih, Hamzah, Tang, Tenglong, Lu, Yang, Thirumurthi, Selvi, Altan, Mehmet, Jazaeri, Amir A., Dadu, Ramona, Coronel, Emmanuel, Wang, Yinghong
Published in J Immunother Cancer (2019)

Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia

by Abu-Sbeih, Hamzah, Ali, Faisal S., Qiao, Wei, Lum, Phillip, Shafi, Mehnaz A., Bresalier, Robert S., Hawk, Ernest, Raju, Gottumukkala S., Wang, Yinghong
Published in J Cancer (2020)